Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metyrapone Intervention in Patients With Mild Autonomous Cortisol Secretion (MACS)

NCT06106295 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06106295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06106295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metyrapone Intervention in Patients With Mild Autonomous Cortisol Secretion (MACS)
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 19, 2023
Completion date
February 1, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autonomous cortisol secretion, mild autonomous cortisol secretion (macs)